Missing: ViOptix's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: ViOptix's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing ViOptix
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
ViOptix is included in 1 Expert Collection, including Medical Devices.
Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)
Latest ViOptix News
Nov 17, 2020
Alexandria–(Global IP News)–United States Patent for oximetry probe with electronically selectable tissue depth analysis has been issued to Vioptix Inc. This invention was developed by Bechtel Kate Leeann, Keating Jennifer Elizabeth and Coleridge Scott. The patent application number is 15/493,111.
ViOptix Frequently Asked Questions (FAQ)
When was ViOptix founded?
ViOptix was founded in 1999.
Where is ViOptix's headquarters?
ViOptix's headquarters is located at 39655 Eureka Drive, Newark.
What is ViOptix's latest funding round?
ViOptix's latest funding round is Series E.
How much did ViOptix raise?
ViOptix raised a total of $29.7M.
Who are the investors of ViOptix?
Investors of ViOptix include Morningside Ventures, Vivo Capital, Channel Medical Partners, Canadian Medical Discoveries Fund, Lincoln Funds International and 6 more.
Who are ViOptix's competitors?
Competitors of ViOptix include CSA Medical, TruTouch Technologies, Ornim Medical, ASL Analytical, AirXpanders and 13 more.
Compare ViOptix to Competitors
Tomophase Corporation was founded with the mission of developing solutions for minimally invasive diagnostic (MID) imaging. The company is using light to guide new ways of diagnosing diseases and has conceived major ideas for an optical MID imaging system
CSA Medical is a developer of cryospray therapy platforms, truFreeze, and Rejuvenair.
Ornim specializes in clinical research, development, and distribution of the highest quality medical devices in the field of tissue and cerebral blood flow and perfusion. The Company's leading product, the c-FLOW, is a bedside patient monitor based on the patented UTLight technology that provides physicians with unique monitoring solutions, revolutionizing individualized and personalized patient care.
ASL Analytical is a business-to-business company developing chemical monitors for the bio-manufacturing market. Using measurement technology, ASL is targeting game-changing advances in the development and production of biopharmaceuticals and other biological-based manufacturing markets.
NICO develops technology for the field of minimally invasive neurosurgery, including skull base and spinal surgery. The company's technology and products are designed and developed to impact patients' lives, families, caregivers, and health system providers. It provides patented technologies that integrate imaging and intervention for approaches to brain surgery. NICO was founded in 2007 and is based in Indianapolis, Indiana.
Nicast is a nano-tech company operatings in the field of tissue engineering, implantable bio-materials and advanced dosage forms. Nicast's matrices mimic biological tissue and therefore allow the creation of artificial organs.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.